WILLIAM ENNIS: Open Payments
NPI 1407199706 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 62 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,234 · 2025 $1,227
Food & beverage: $1,227
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $222 |
| PFIZER INC. | 9 | $168 |
| Lilly USA, LLC | 7 | $148 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Phathom Pharmaceuticals, Inc. | 4 | $74 |
| Exact Sciences Corporation | 3 | $63 |
| Amgen Inc. | 3 | $51 |
| Lundbeck LLC | 2 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
Products named: MOUNJARO, UBRELVY, QULIPTA, ELIQUIS, VOQUEZNA, Cologuard Collection Kit, OTEZLA, REXULTI.
Industry payments across MD — which companies pay providers there.
